CSBio
Wei Wang is an experienced professional in the pharmaceutical industry, currently serving as Vice President of Production at Bachem since September 2020, where responsibilities include the manufacturing of peptides as active pharmaceutical ingredients (API) and drug candidates in compliance with cGMP regulations, along with the commercial production of PMO drug substances. Prior to this role, Wei Wang held multiple positions at CSBio Co., initially as Vice President of Development & Quality Control from February 2018 to September 2020, and earlier as Vice President of Research & Development and Director from February 2010 to February 2018, demonstrating a strong background in development, quality control, and research.
This person is not in any offices
CSBio
CSBio is a leading peptide and peptide synthesizer manufacturing company located on the edge of Silicon Valley in Menlo Park, California. Since 1993, CSBio has been providing high quality custom peptides, cGMP peptides and automated peptide synthesizers to the global biotech community. Our peptide products and peptide synthesis equipment can be found in peptide production laboratories and pharmaceutical companies worldwide. CSBio now also offers solid phase peptide synthesis resins as well as high quality Fmoc and Boc protected amino acids for use in both R&D and cGMP peptide manufacturing. Our state of the art cGMP manufacturing facility provides cGMP peptides for preclinical and clinical programs and our commercialization and regulatory teams can take you from toxicology studies through market commercialization. Our product line also includes a complete list of generic peptide APIs including the most widely used peptide APIs in the industry. Whatever your peptide requirements, CSBio can assist you in reaching your ultimate goals by offering high quality products and world class support.